Plager D A, Stuart S, Gleich G J
Department of Immunology, Mayo Clinic and Foundation, Rochester, MN 55905, USA.
Allergy. 1998;53(45 Suppl):33-40. doi: 10.1111/j.1398-9995.1998.tb04937.x.
Human MBP is associated with an array of in vitro cytotoxic and cytostimulatory activities, mediated in part by its strong basicity. It is most prominently found in the eosinophil, but is also present in placental X cells and placental-site giant cells during pregnancy. Pathologically, its pattern of tissue deposition and its ability to induce characteristic pathophysiologic changes, such as bronchial hyperreactivity and vasopermeability, strongly suggest a role for MBP in allergic and eosinophilic diseases. The role of MBP in protection from helminthic disease is also evident. Here, we present information on a novel homolog of eosinophil granule MBP with biologic activities similar to that of MBP. However, results from experiments on eosinophil granules suggest that the quantity of the homolog present in the eosinophil granule is significantly less than that of MBP itself. Further, preliminary experiments indicate that the two proteins are not synergistic in terms of their cytotoxic and cytostimulatory biologic activities. Future experiments must determine whether the MBP homolog is deposited at sites of tissue damage and can be detected in biologic fluids at concentrations required for biologic activity.
人髓磷脂碱性蛋白(MBP)与一系列体外细胞毒性和细胞刺激活性相关,部分由其强碱性介导。它最显著地存在于嗜酸性粒细胞中,但在怀孕期间的胎盘X细胞和胎盘部位巨细胞中也存在。在病理上,其组织沉积模式以及诱导特征性病理生理变化(如支气管高反应性和血管通透性)的能力,强烈提示MBP在过敏性和嗜酸性疾病中起作用。MBP在预防蠕虫病中的作用也很明显。在此,我们展示了一种嗜酸性粒细胞颗粒MBP的新型同源物的信息,其生物活性与MBP相似。然而,对嗜酸性粒细胞颗粒的实验结果表明,嗜酸性粒细胞颗粒中存在的同源物数量明显少于MBP本身。此外,初步实验表明,这两种蛋白质在细胞毒性和细胞刺激生物活性方面不存在协同作用。未来的实验必须确定MBP同源物是否沉积在组织损伤部位,以及能否在生物活性所需浓度的生物体液中检测到。